Kinase targets in CNS drug discovery

QR Code

Kinase targets in CNS drug discovery

Originally thought to be nondruggable, kinases represent attractive drug targets for pharmaceutical companies and academia. To date, there are over 40 kinase inhibitors approved by the US FDA, with 32 of these being small molecules, in addition to the three mammalian target of rapamycin inhibitor ma...

Full description

Bibliographic Details
Main Authors:	Gunosewoyo, Hendra, Yu, L., Munoz, L., Kassiou, M.
Format:	Journal Article
Published:	2017
Online Access:	http://hdl.handle.net/20.500.11937/50188

Similar Items

The First CNS-Active Carborane: A Novel P2X7 Receptor Antagonist with Antidepressant Activity
by: Wilkinson, S., et al.
Published: (2014)

Tuberculosis: Pathogenesis, Current Treatment Regimens and New Drug Targets
by: Alsayed, S.S.R., et al.
Published: (2023)

P2X purinergic receptor ligands: recently patented compounds
by: Gunosewoyo, Hendra, et al.
Published: (2010)

Kinase Targets for Mycolic Acid Biosynthesis in Mycobacterium tuberculosis.
by: Alsayed, S., et al.
Published: (2018)

Development of antidepressant drugs through targeting a4ß2-nicotinic acetylcholine receptors
by: Zhang, H., et al.
Published: (2016)

Class II Phosphoinositide 3-Kinases as Novel Drug Targets
by: Falasca, Marco, et al.
Published: (2017)

Case Studies of Non-CNS Drugs to Minimise Brain Penetration - Nonsedative Antihistamines
by: Crowe, Andrew
Published: (2015)

Molecular Probes for P2X7 Receptor Studies
by: Gunosewoyo, Hendra, et al.
Published: (2007)

From a4ß2 Nicotinic Ligands to the Discovery of σ1 Receptor Ligands: Pharmacophore Analysis and Rational Design
by: Yu, L., et al.
Published: (2012)

Purinergic P2X7 Receptor Antagonists: Chemistry and Fundamentals of Biological Screening
by: Gunosewoyo, Hendra, et al.
Published: (2009)

Cubyl amides: Novel P2X7 receptor antagonists
by: Gunosewoyo, Hendra, et al.
Published: (2008)

CLIPPERS the brain biter: An adolescent’s experience of a rare CNS disorder
by: Anuar, Muhamad Azamin, et al.
Published: (2019)

Pseudomonas aeruginosa quorum sensing systems as drug discovery targets: current position and future perspectives
by: Soukarieh, Fadi, et al.
Published: (2018)

Cyclin dependent Kinases as potential therapeutic targets for atherosclerosis
by: Rostam, Muhamad Ashraf, et al.
Published: (2015)

Annexin A2 extracellular translocation and virus interaction: a potential target for antivirus‐drug discovery
by: Chee, Hui Yee, et al.
Published: (2019)

Molecular Cloning, Expression, And Characterization Of Glutathione-Stransferase As A Novel Target In Antimalarial Drug Design And Discovery
by: Al-Qattan, Mohammed Nooraldeen Mahmod
Published: (2015)

Structure-Guided Design of a Highly Selective Glycogen Synthase Kinase-3ß Inhibitor: A Superior Neuroprotective Pyrazolone Showing Antimania Effects
by: Chen, W., et al.
Published: (2011)

Self-assembling tyrosine kinase inhibitors for localised targeted delivery
by: Al-Ameedee, Mohammed
Published: (2017)

In silico discovery of potential uridine-cytidine kinase 2 inhibitors form the rhizome of Alpina mutica
by: Malami, Ibrahim, et al.
Published: (2016)

The importance of in-silico studies in drug discovery
by: Roney, Miah, et al.
Published: (2024)

The evolutionary development in drug discovery and delivery
by: Ithnin, Hairuszah, et al.
Published: (2013)

Characterization of Maleimide-Based Glycogen Synthase Kinase-3 (GSK-3) Inhibitors as Stimulators of Steroidogenesis
by: Gunosewoyo, Hendra, et al.
Published: (2013)

Drug discovery and development: a historical overview, current challenges and perspectives
by: Yu, Chai Xin, et al.
Published: (2024)

Direct exposure of guinea pig CNS to human luteinizing hormone increases cerebrospinal fluid and cerebral beta amyloid levels
by: Wahjoepramono, E., et al.
Published: (2011)

An apoferritin-based drug delivery system for the tyrosine kinase inhibitor gefitinib
by: Kuruppu, Anchala I., et al.
Published: (2015)

Screening techniques for drug discovery in Alzheimer's disease
by: Maniam, Sandra, et al.
Published: (2024)

Identification of a Glycogen Synthase Kinase-3β Inhibitor that Attenuates Hyperactivity in CLOCK Mutant Mice
by: Kozikowski, A., et al.
Published: (2011)

AI-Based Drug Design: Revolutionizing Drug Discovery through in Silico Analysis
by: Yamini Priya, Deepthimahanthi, et al.
Published: (2023)

Bone drug targets
by: Dass, Crispin
Published: (2018)

Phosphoinositide 3-kinase pathway inhibitors: pharmacology, metabolism & drug development
by: Falasca, Marco
Published: (2011)

Study on the antibacterial effect on kalanchoe pinnata against coagulase negative staphylococcus (CNS) / Nor Syahira Yusoff
by: Yusoff, Nor Syahira
Published: (2017)

The role of the WNT/β-catenin pathway in central nervous system primitive neuroectodermal tumours (CNS PNETs)
by: Rogers, H.A., et al.
Published: (2013)

MRI findings of intracranial primary CNS lymphoma in immunocompetent patients: a Malaysian tertiary hospital experience
by: Ab Rahman, Siti Soraya, et al.
Published: (2020)

A practical drug discovery project at the undergraduate level
by: Fray, Michael J., et al.
Published: (2013)

Discovery of highly potent and selective phosphatidylinositol 3-kinase-δ inhibitors for the treatment of blood cancers and autoimmune diseases
by: Buzrieda, Anas
Published: (2021)

Targeted RNAi of the mitogen-activated protein kinase pathway genes in acute myeloid leukemia cells
by: Mohd Hafiz, M.R., et al.
Published: (2013)

The structural modification of natural products for novel drug discovery
by: Yao, Hong, et al.
Published: (2016)

The extracellular signal-regulated kinase (ERK) pathway: a potential therapeutic target in hypertension
by: Roberts, Richard E.
Published: (2012)

3-phosphoinositide-dependent protein kinase-1 as an emerging target in the management of breast cancer
by: Fyffe, C., et al.
Published: (2013)

PCR assays in detecting methicillin resistance in staphylococci: Coagulase negative staphylococci (CNS), S. aureus, and MRSA with the PVL gene
by: Merlino, J., et al.
Published: (2010)